• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

#vraylarbpdmeeting

  1. Sent home from Allergan Vraylar Launch Meeting?

    So who has the scoop on what happened to get two people sent home from the Vraylar launch meeting? What got posted on social media?